Pharma major Mylan on Monday said it has commercially launched the generic version of Remdesivir drug under the brand name 'Desrem' in India for treatment of coronavirus patients.
The US Food and Drug Administration (USFDA) has accepted biologics license application by Mylan and Biocon for proposed biosimilar to Bevacizumab for review, according to a regulatory filing.
New Delhi: The Foreign Investment Promotion Board (FIPB) has cleared US-based pharmaceutical firm Mylan Inc's Rs 5,168 crore proposal to acquire Indian generic drugs company Agila Specialties.The proposal will now have to be approved by
Top News
Latest News
